Lanraplenib Uses, Dosage, Side Effects and more
Lanraplenib is under investigation in clinical trial NCT03285711 (Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)).
| Attribute | Details |
|---|---|
| Trade Name | Lanraplenib |
| Generic | Lanraplenib |
| Lanraplenib Other Names | Lanraplenib |
| Type | |
| Formula | C23H25N9O |
| Weight | Average: 443.515 Monoisotopic: 443.218206461 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
